OraSure Technologies to Present at the Piper Jaffray 31st Annual Healthcare Conference

Loading...
Loading...

BETHLEHEM, Pa., Nov. 26, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. OSUR, a leader in point-of-care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the Piper Jaffray 31st Annual Healthcare Conference. The conference will be simultaneously webcast over the Internet. 

Dr. Tang is scheduled to speak on Wednesday, December 4, 2019, at approximately 12:10 PM Eastern Time (9:10 AM Pacific Time). Interested investors can access the live webcast of the presentation by going to OraSure Technologies' web site, www.orasure.com and clicking on the Investors link. A replay of the webcast will be available on OraSure Technologies' web site for seven days. Alternatively, you can access the live webcast of the presentation via the following link: https://event.webcasts.com/starthere.jsp?ei=1273813&tp_key=c8662f7231.

About OraSure Technologies

OraSure Technologies is empowering the global community to improve health and wellness by providing access to accurate essential information. OraSure is a leader in the development, manufacture and distribution of point-of-care diagnostic tests, molecular collection devices and other technologies designed to detect or diagnose critical medical conditions. Its first-to-market, innovative products include rapid tests for the detection of antibodies to HIV and Hepatitis C (HCV) on the OraQuick® platform, sample self-collection and stabilization products for molecular applications, and oral fluid laboratory tests for detecting various drugs of abuse. Together with its wholly-owned subsidiaries (DNA Genotek, CoreBiome, Diversigen and Novosanis), OraSure provides its customers with value-added, end-to-end solutions that encompass tools, diagnostics and services. OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research institutions, distributors, government agencies, physicians' offices, commercial and industrial entities and consumers. For more information on OraSure Technologies, please visit www.orasure.com.

Company contact:

Roberto CucaJeanne Mell
Chief Financial OfficerVP Corporate Communications
610-882-1820484-353-1575
Investorinfo@orasure.commedia@orasure.com
www.orasure.comwww.orasure.com

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsHealth CarePress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...